Close Menu

A Gift from Merck

Open Access News highlights a recent blog post by John Wilbanks, announcing that Merck will establish a nonprofit called Sage to create an open-access database about the biology of disease, as well as software tools to use it. According to Wilbanks, who is on the founding board of directors for Sage, "It's not about making a quick data dump onto the web, however.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.